logo
Domestic med-tech companies flag security threat from Chinese devices

Domestic med-tech companies flag security threat from Chinese devices

Time of India17 hours ago
Indian medical tech leaders have voiced concerns to the government regarding the security risks associated with importing Chinese healthcare devices. They highlighted potential misuse for surveillance, cyberattacks, and data breaches, urging stricter scrutiny and measures to prevent rerouting via other countries. Manufacturers also seek streamlined regulations and policy support to boost domestic production and achieve self-reliance.
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
New Delhi: India's medical tech leaders have urged the government to scrutinise imports of Chinese healthcare devices , citing security threat as these modern machines can be potentially misused for surveillance, cyberattacks and data breach.At a recent meeting with commerce and industry minister Piyush Goyal, domestic manufacturers raised concerns over increasing deployment of Chinese imagining and monitoring equipment in healthcare facilities across the country."Chinese products are everywhere in the market and data is going to the Chinese companies," an industry executive who attended the meeting told ET. "Medical devices are not just medical devices, they can be means of military defence."Keeping in view the gravity of the situation, the government has agreed to take up the matter at the highest level, industry executives said.Modern medical equipment such as MRI machines, pacemakers, and diagnostic devices often come with internet connectivity and cloud-based data storage. They can be used as tools in grey zone warfare. Hence, it is important not to source these products from hostile nations, manufacturers said.They also urged the government to put in place necessary checks and balances to ensure there is no re-routing of Chinese devices via other countries."Without firing a single bullet, a hostile nation can rig the devices (with bugs or malware) and use them as secret weapons," a second executive said."Population health data can be misused by Chinese firms using Chinese-owned medical devices, especially IoT (internet of things)-enabled imagining and monitoring equipment," the person said. "A lot of such equipment is installed in the country."Some countries have already banned imports of medical equipment from certain countries and companies, device manufacturers said.They also flagged issues regarding indirect dumping of Chinese products via transit countries such as Hong Kong, Malaysia, Singapore or other countries that have a free trade agreement (FTA) with India.The US is the dominant supplier of medical equipment to India, with an estimated 18% share (shipping devices worth ₹12,552 crore in 2023-24), China is a close second with 16.4% share (₹11,506 crore in FY24).In the meeting early this month, Indian medical device manufacturers and exporters also highlighted challenges they face, including high regulatory costs, long approval timelines, and a lack of focused product strategy. "Streamlining regulatory processes and enhancing policy support are seen as essential steps to revive growth and move towards a self-reliant Atmanirbhar Bharat," said an executive who attended the meeting.Rajiv Nath, forum coordinator at Association of Indian Medical Device Industry (AiMeD), urged the government to act on the six strategy frameworks announced in the National Medical Devices Policy, 2023, aimed at making India a global manufacturing hub. This is crucial "considering the potential adverse impact of US trade negotiations seeking duty reductions for their medical devices" as part of the proposed India-US bilateral trade pact, he said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Indian medical tourism market to surge from $18.2 bn in 2025 to $58.2 bn by 2035: Report
Indian medical tourism market to surge from $18.2 bn in 2025 to $58.2 bn by 2035: Report

Hans India

time20 minutes ago

  • Hans India

Indian medical tourism market to surge from $18.2 bn in 2025 to $58.2 bn by 2035: Report

New Delhi: The Indian medical tourism market is set to surge from $18.2 billion in 2025 to $58.2 billion by 2035, according to a new report on Thursday. The report, by the Federation of Hotel and Restaurant Associations of India (FHRAI), in collaboration with KPMG, showcased the country's ambitious vision to become the global medical hub by 2035, rising at a CAGR of 12.3 per cent. The report also outlines a transformative national strategy that integrates India's clinical expertise with its centuries-old wellness traditions, aiming to make the country the world's most trusted destination for medical value travel (MVT). It showed that India is emerging as a cost-effective alternative offering both modern surgeries and natural recovery options like Ayurveda, Yoga, and Panchakarma. India ranks 10th in the Medical Tourism Index and seventh in wellness tourism, and attracts nearly 2 million international patients from 75 countries. The report showed that medical visa issuance rose to 463,725 in 2024, with the majority of patients from Bangladesh, GCC nations, and Africa. Ayurveda and traditional medicine are gaining significant global importance, said Dr. Manoj Nesari, from the Ministry of Health and Family Welfare, while unveiling the report at the Heal in India 2025 Medical and Wellness Tourism Summit, organised by the FHRAI in the national capital. "India is very rich in traditional healing, and the government has taken a plethora of initiatives to boost this sector as an alternate economy in recent years,' he said, adding that a series of initiatives have been taken to further promote Yoga and Ayurveda as a healing and wellness alternative across the globe. Suman Billa, IAS, Additional Secretary and Director General, Ministry of Tourism, noted that the tourism economy is reaching $3 trillion in the coming years, and for that, several areas need to be activated. 'Medical and wellness tourism are strategic pillars to achieve this target. He strongly suggested that in the coming years we will have to showcase not only our competence but also our care, compassion, and delivery,' he said.

Unsafe gains: 14% of Indian protein powders have toxins, 70% mislabelled
Unsafe gains: 14% of Indian protein powders have toxins, 70% mislabelled

Business Standard

time20 minutes ago

  • Business Standard

Unsafe gains: 14% of Indian protein powders have toxins, 70% mislabelled

In a wake-up call for India's growing fitness and wellness industry, a peer-reviewed study has revealed that 70 per cent of 36 popular protein supplements sold in India were mislabelled, while 14 per cent were found to contain dangerous toxins including heavy metals, pesticides, and fungus-derived aflatoxins. The study, titled 'Citizen's Protein Project' and published in the journal Medicine, was a self-funded initiative by researchers and concerned citizens to investigate what exactly goes into the most widely consumed protein powders in the Indian market. What's wrong with the protein powder you're consuming? The study, which involved laboratory testing of 36 protein powder samples, was conducted by researchers from Rajagiri Hospital (Kerala) and a US-based technology entrepreneur. Key findings include: 70 per cent samples misrepresented their protein content 14 per cent samples were contaminated with aflatoxins (toxic compounds produced by moulds/fungus) 8.3 per cent were found to be contaminated by pesticide residues According to the study, most of the samples were contaminated with heavy metals: - Arsenic was detected in 13.9 per cent of the samples - Cadmium in 27.8 per cent samples - Lead in 75 per cent samples - Copper in 94.4 per cent samples - None of the protein powder contained mercury or thallium Ingredients such as green tea extract, curcumin, garcinia cambogia and ashwagandha, which can be damaging for the liver in large doses, were present in several formulations. A wide variety of other types of industrial solvents, such as alcohols, phenols, aldehydes, ketones, and esters, were also detected in various samples. Certain brands contained more than the labelled or advertised protein content, raising concerns of protein/amino-spiking with low quality ingredients. Health Implications Prolonged exposure to these contaminants can lead to serious health problems such as liver damage, kidney dysfunction, hormonal imbalance, and even carcinogenic effects. The World Health Organisation states that there is no safe level of Pb exposure. The International Agency for Research on Cancer (IARC) classifies aflatoxins as potentially carcinogenic for humans. "Heavy metals such as lead, mercury, and arsenic can gradually accumulate in the body over time, damaging vital organs like the liver, kidneys, and brain. This build-up may lead to complications such as nerve damage, memory loss, and even organ failure. Pesticides disrupt hormonal balance, weaken the immune system, and potentially raise the risk of certain cancers," Dr K Sridhar Srinivasan, senior consultant for Internal Medicine at CARE Hospitals, told Business Standard. "Aflatoxins, which are toxic compounds produced by certain fungi, are particularly hazardous. Prolonged exposure to aflatoxins can severely harm the liver and significantly increase the risk of developing liver cancer," he added. Gaps in regulation and quality control According to a report by Mordor Intelligence, the India protein market size is estimated at $1.52 billion in 2025, and is expected to reach $2.08 billion by 2030, growing at a CAGR of 6.52 per cent during the forecast period of 2025-2030. Despite the growing market, the industry remains poorly regulated in India. Unlike pharmaceuticals, dietary supplements are not subject to strict pre-market approval. The Citizen's Protein Project report states that similar to the United States Food and Drug Administration, the Food Safety and Standards Authority of India (FSSAI) does not approve herbal and dietary supplements (HDS). The safety of contents must be assured by the manufacturer, while the content and labelling are scrutinised by the FSSAI based on test results submitted by the manufacturer, that are not made public and remain non-transparent. The authors of the study have urged stricter enforcement by regulatory bodies like FSSAI, calling for: routine third-party lab testing transparent labelling practices mandatory disclosures of ingredient sources Adding to the discourse, Dr Srinivasan said, "All supplement brands should go through independent lab testing, and if they are found to be unsafe or mislabelled, they must face heavy penalties. There should also be a central database or website where consumers can check which brands are tested and approved. The FSSAI must ensure that labels clearly mention test certifications and ingredient details." What can consumers do? For now, experts advise buyers to remain cautious. Buy only from trusted and certified brands. Always check for FSSAI approval and lab certifications. Avoid products promoted only by celebrities or influencers without medical backing. Whenever possible, try to get protein from natural food sources like milk, pulses, eggs, fish, nuts, etc. Before starting any supplement, it's best to talk to a doctor or dietician to know if it's really needed.

Post ISS mission, Shux in good health
Post ISS mission, Shux in good health

United News of India

time32 minutes ago

  • United News of India

Post ISS mission, Shux in good health

Chennai, July 17 (UNI) The health condition of decorated piot Shubhanshu Shukla, who became the first Indian astronaut to travel to International Space Station and returned after a 18-day stay, was stable and in good health, ISRO said today. After Gaganyatri Shubhanshu Shukla was extracted by SpaceX's recovery teams on July 15, 2025, preliminary health checks were carried out at recovery ship. Initial health assessments indicated that Gaganyatri Shukla was in stable condition with no immediate concerns reported. He was airlifted by helicopter from the recovery ship to the mainland for further medical evaluations and debriefing sessions. Later, Shubhanshu Shukla was flown to Houston for a week-long rehabilitation program to mitigate any adverse effect of microgravity. This is being administered by Axiom's flight surgeon and ISRO's flight surgeon is also participating in this program. This includes a series of medical checks especially cardiovascular assessments, musculoskeletal tests psychological debrief. The rehabilitation activities of Gaganyatri focus on monitoring physical and mental health, addressing any effects of microgravity, and preparing him for a return to normal activities. Shux and three other crew members from US, Hungary and Poland, took off for ISS on June 25 and docked the next day after a 28 hr flight journey. After an extended 18 day stay, during which Shux conducted seven microgravity experiments of iSRO, undocked from ISS on July 14 and the Dragon spacecraft splashed down off California coast after a 22.5 hr journey the next day. Shux was the second Indian to travel to space after a gap of 41 years when Rakesh Sharma travelled in 1984. UNI GV 1515

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store